1. Home
  2. CADL vs AIIO Comparison

CADL vs AIIO Comparison

Compare CADL & AIIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$9.46

Market Cap

694.6M

Sector

Health Care

ML Signal

HOLD

Logo Robo.ai Inc. Class B Ordinary Shares

AIIO

Robo.ai Inc. Class B Ordinary Shares

HOLD

Current Price

$2.67

Market Cap

670.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
AIIO
Founded
1999
N/A
Country
United States
United Arab Emirates
Employees
N/A
29
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
694.6M
670.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
AIIO
Price
$9.46
$2.67
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.4M
1.6M
Earning Date
05-14-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$0.07
52 Week High
$11.36
$9.20

Technical Indicators

Market Signals
Indicator
CADL
AIIO
Relative Strength Index (RSI) 50.20 40.70
Support Level $9.19 $0.34
Resistance Level $11.36 $4.96
Average True Range (ATR) 0.58 0.50
MACD -0.07 -0.20
Stochastic Oscillator 24.29 4.87

Price Performance

Historical Comparison
CADL
AIIO

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About AIIO Robo.ai Inc. Class B Ordinary Shares

Robo.ai Inc is a decentralized, AI-powered intelligent mobility platform that integrates smart vehicles, robotics, and blockchain technologies. The company is developing an AI-NAS ecosystem focused on delivering a passenger-centric platform by combining hardware and software, leveraging onboard computing, and offering an open cloud environment. Its product portfolio includes MUSE, a full-sized autonomous electric SPV; GHIATH, a purpose-built vehicle for public services and law enforcement developed in collaboration with Dubai Police; and Astra, an autonomous logistics vehicle. It also offers other vehicle models such as NWONE (SUV), Rabdan One (SUV), and Rabdan Seven (MPV) in the UAE through the SKD model. The company operates across the USA, UAE, and Mainland China.

Share on Social Networks: